121 related articles for article (PubMed ID: 29928389)
1. Novel insights into biomarkers associated with renal cell carcinoma.
Chen B; Jiao Z; Yin X; Qian Z; Gu J; Sun H
Oncol Lett; 2018 Jul; 16(1):83-90. PubMed ID: 29928389
[TBL] [Abstract][Full Text] [Related]
2. Identifying the novel key genes in renal cell carcinoma by bioinformatics analysis and cell experiments.
Chen Y; Gu D; Wen Y; Yang S; Duan X; Lai Y; Yang J; Yuan D; Khan A; Wu W; Zeng G
Cancer Cell Int; 2020; 20():331. PubMed ID: 32699530
[TBL] [Abstract][Full Text] [Related]
3. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
Li F; Guo P; Dong K; Guo P; Wang H; Lv X
J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
[No Abstract] [Full Text] [Related]
4. The IGF2BP3-COPS7B Axis Facilitates mRNA Translation to Drive Colorectal Cancer Progression.
Tang J; Wang S; Weng M; Guo Q; Ren L; He Y; Cui Z; Cong M; Qin M; Yu J; Su R; Li X
Cancer Res; 2023 Nov; 83(21):3593-3610. PubMed ID: 37560971
[TBL] [Abstract][Full Text] [Related]
5. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
[TBL] [Abstract][Full Text] [Related]
6. Identification of hub genes associated with outcome of clear cell renal cell carcinoma.
Li R; Wang L; Wang X; Geng RX; Li N; Liu XH
Oncol Lett; 2020 Apr; 19(4):2846-2860. PubMed ID: 32218839
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the microRNA-target gene regulatory network in renal cell carcinomas, identification for potential biomarkers and critical pathways.
Li J; Huang JH; Qu QH; Xia Q; Wang DS; Jin L; Sheng C
Int J Clin Exp Med; 2015; 8(5):7209-19. PubMed ID: 26221260
[TBL] [Abstract][Full Text] [Related]
8. A five-gene signature may predict sunitinib sensitivity and serve as prognostic biomarkers for renal cell carcinoma.
Chen YL; Ge GJ; Qi C; Wang H; Wang HL; Li LY; Li GH; Xia LQ
J Cell Physiol; 2018 Oct; 233(10):6649-6660. PubMed ID: 29327492
[TBL] [Abstract][Full Text] [Related]
9. Identification of
Wang S; Yu ZH; Chai KQ
Oncol Lett; 2019 Aug; 18(2):1767-1774. PubMed ID: 31423244
[TBL] [Abstract][Full Text] [Related]
10. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
Zhou WM; Wu GL; Huang J; Li JG; Hao C; He QM; Chen XD; Wang GX; Tu XH
Cell Signal; 2019 Apr; 56():1-14. PubMed ID: 30465826
[TBL] [Abstract][Full Text] [Related]
11. PTBP1 knockdown in renal cell carcinoma inhibits cell migration, invasion and angiogenesis in vitro and metastasis in vivo via the hypoxia inducible factor-1α pathway.
Shan H; Hou P; Zhang M; Li L; Pan Y; Chen F; Jiang T; Bai J; Zheng J
Int J Oncol; 2018 May; 52(5):1613-1622. PubMed ID: 29512730
[TBL] [Abstract][Full Text] [Related]
12. Microarray profiling of human renal cell carcinoma: identification for potential biomarkers and critical pathways.
Li W; Zhu W; Che J; Sun W; Liu M; Peng B; Zheng J
Kidney Blood Press Res; 2013; 37(4-5):506-13. PubMed ID: 24247930
[TBL] [Abstract][Full Text] [Related]
13. The screening of pivotal gene expression signatures and biomarkers in renal carcinoma.
Ruan H; Li S; Tong J; Cao Q; Song Z; Wang K; Huang Y; Bao L; Chen X; Yang H; Chen K; Zhang X
J Cancer; 2019; 10(25):6384-6394. PubMed ID: 31772671
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatic analysis identifies potentially key differentially expressed genes in oncogenesis and progression of clear cell renal cell carcinoma.
Zhang H; Zou J; Yin Y; Zhang B; Hu Y; Wang J; Mu H
PeerJ; 2019; 7():e8096. PubMed ID: 31788359
[TBL] [Abstract][Full Text] [Related]
15. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
[TBL] [Abstract][Full Text] [Related]
16. The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1/G3BP1-SPP1- NF-κB signaling axis.
Wang Y; Su J; Wang Y; Fu D; Ideozu JE; Geng H; Cui Q; Wang C; Chen R; Yu Y; Niu Y; Yue D
J Exp Clin Cancer Res; 2019 Sep; 38(1):386. PubMed ID: 31481087
[TBL] [Abstract][Full Text] [Related]
17. Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis.
Wang S; Yu ZH; Chai KQ
Biomed Res Int; 2019; 2019():6480865. PubMed ID: 30895194
[TBL] [Abstract][Full Text] [Related]
18. Screening of feature genes of the renal cell carcinoma with DNA microarray.
Feng JY; Diao XW; Fan MQ; Wang PX; Xiao Y; Zhong X; Wu RH; Huang CB
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(22):2994-3001. PubMed ID: 24302177
[TBL] [Abstract][Full Text] [Related]
19. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
Wan Z; Zhang X; Luo Y; Zhao B
Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
[No Abstract] [Full Text] [Related]
20. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
